Seeking Alpha

Enzon, Inc. (ENZN)

()

News & PR
Market Currents

Buzz
Twitter: ENZN

Business Intelligence
Transcripts
Events
Key Developments

Analysis - Latest Articles by most recent | most commented

Baupost to Purchase More Facet Biotech: What About Biogen Idec?

Dec 16 • Market Folly • 2 Comments
Baupost Trims Syneron Stake

Dec 10 • Market Folly • 2 Comments
Klarman, Whitman Are Sellers But Witmer Buys in Q3 2009

Nov 18 • Davy Bui • Comment!
Seth Klarman's Baupost Group Q3 Portfolio: Two Changes of Note

Nov 17 • Market Folly • 10 Comments
Baupost Initiates Enzon Position, Ups ViaSat Stake

Nov 11 • Market Folly • Comment!
23 Bullish Breakouts on Big Volume

Nov 10 • Marco Hickey • 1 Comment
15 Breakout Stocks on Huge Volume

Oct 8 • Marco Hickey • 1 Comment
Three Recent Biotech Activist Wins by Carl Icahn

Aug 31 • Michael Becker • 4 Comments
Smart Money Moves in Q109

May 18 • The Inoculated Investor • 2 Comments
Carl Icahn's Top Three Stock Ideas

Mar 5 • The Manual of Ideas • 2 Comments
Does Icahn's Involvement Affect Share Price in the Long Run?

Jul 25, 2008 • Markham Lee • 3 Comments
Enzon Shareholders Demand Change

May 21, 2008 • Eben Tessari • Comment!
Enzon Shareholder Demands Possible Sale of Commercial Operations Be Explored

May 21, 2008 • Lon Juricic • Comment!
Icahn Steals The Future of Enzon Pharmaceuticals

May 8, 2008 • Eben Tessari • 9 Comments
Carl Icahn Boosts Stake in Enzon Pharm

Mar 17, 2008 • Lon Juricic • Comment!
Large Enzon Holder Wants Company To Unlock Value

Dec 19, 2007 • Lon Juricic • 1 Comment
Will Icahn Find Activist Success in the Biopharmaceutical Arena?

Oct 16, 2007 • Lon Juricic • Comment!
Icahn Management Releases Latest 13F: Summary of Holdings

Aug 16, 2007 • Lon Juricic • Comment!
Cancer Stocks Hammered Once Again

Jun 26, 2007 • Alan Brochstein • 7 Comments
Cancer Stocks Slide Again

Jun 18, 2007 • Alan Brochstein • 1 Comment
Cancer Stocks Plunge Following ASCO Meeting

Jun 11, 2007 • Alan Brochstein • 3 Comments
Cancer Stocks Soar With Annual ASCO Meeting

Jun 4, 2007 • Alan Brochstein • 1 Comment
Cancer Stocks on the Go: Winners and Losers

May 29, 2007 • Alan Brochstein • 3 Comments
Biotech Day In Review: CuraGen Gets $155 Million For Gene Sequence Division

Mar 30, 2007 • Centient Biotech Investor • 1 Comment
Renaissance Technologies: "Black-Box" Hedge Fund Discloses New Positions

Feb 13, 2007 • Lon Juricic • Comment!
Biotech Stocks Day-In-Review: Amgen Drags Biotech Lower

Jan 28, 2007 • Centient Biotech Investor • Comment!
Biotech Stocks Day-in-Review: Controversy For Genentech Cancer Drug

Jan 7, 2007 • Centient Biotech Investor • Comment!

Enzon, Inc. (ENZN)

Analysis - Latest Articles by most recent | most commented

The Seeking Alpha 100

Fastest Climbers

Top Commenters

Top Instabloggers

Top StockTalkers